The physical, psychological, and cytogenetic characteristics of individuals with the Fragile X syndrome were reviewed. Prospects for therapy with folic acid, prenatal diagnosis, phenotype of heterozygotes for the marker X, and unresolved issues about the syndrome were discussed.